Skip to content

Psychedelic-assisted therapy: all studies

Page 169 of 294: studies 1,681 to 1,690 of 2,939, newest first. Back to the psychedelic-assisted therapy overview

Research

Tū Wairua: Development of an Indigenous Rongoā Māori approach to healing with psilocybin containing mushrooms

Journal of Psychedelic Studies May 16, 2025 Anna-Leigh Hodge, Anna Forsyth, Tehseen Noorani et al. 6 citations

Abstract Psilocybin, a naturally occurring psychedelic compound found in certain fungi has long been used by Indigenous cultures within ritual and ceremony for healing and spiritual purposes (Spiers et al., 2024). While emerging evidence points to psychedelic agents being novel avenues for the treatment of substance use disorders, the predominantly Western medical models of psychedelic-assisted...

A primer for culturally attuned psychedelic clinical trials

Journal of Psychedelic Studies May 15, 2025 Terence H. W. Ching, Benjamin Kelmendi 4 citations

AbstractBackgroundThere is a need to systemically diversify psychedelic clinical trials, considering the growing interest in in the therapeutic potential of psychedelics within Black, Indigenous, and Peoples of Color (BIPOC) and queer communities. Doing so contributes to a more inclusive foundation of evidence-based research and addresses ethical considerations surrounding anticipated demand...

The Intersection of Psychedelics and Sleep: Exploring the Impacts on Sleep Architecture, Dream States, and Therapeutic Implications

ACS Pharmacology & Translational Science May 15, 2025 Haojiang Zhai, Hongshuang Wang, Haohong Li et al. 3 citations

The interplay between psychedelics, such as psilocybin, lysergic acid diethylamide (LSD) and dimethyltryptamine (DMT), and sleep is an emerging area, but their impact on sleep remains relatively underexplored. This viewpoint provides a perspective on how psychedelics may alter sleep phases, dreaming, and their potential therapeutic applications for sleep disorders.

DOI: 10.1021/acsptsci.5c00234 (opens in new tab) Psilocybin Insomnia Psychedelics Profoundly impact +7

Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes

Frontiers in Psychology May 15, 2025 Jake Hooper, Emily L Gyongyosi, Kent E. Hutchison et al. 5 citations

Introduction The aesthetic qualities of psychedelic experiences have long been documented, but their specific contribution to therapeutic outcomes remains understudied. Aesthetic experiences may facilitate emotional breakthroughs and cognitive shifts, potentially playing a crucial role in the lasting psychological benefits observed following psychedelic use. Methods This cross-sectional study...

DOI: 10.3389/fpsyg.2025.1533055 (opens in new tab) Aesthetic Emotion Insight Psychedelics +4

Cornutopia: A short story and what it can tell us about ethnic minority views on psychedelic research, and the potential impact on clinical outcomes

Journal of Psychedelic Studies May 13, 2025 Caroline Hayes

Abstract The fictional story, Cornutopia , by British-Nigerian author Irenosen Okojie, offers a critical outsider's perspective on the enthusiasm surrounding psychedelic research, notably from outside the small world of psychedelic research. The protagonist, Amel Dyani, a young Black woman, participates in a psychedelic clinical trial but has a negative experience. This article aims to analyse...

Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.

ACS Chemical Neuroscience May 7, 2025 Hongshuang Wang, Xiaohui Wang 5 citations

This viewpoint explores the therapeutic potential of psychedelics in treating neuropsychiatric disorders, particularly through the modulation of brain entropy and the experience of ego dissolution. Psychedelics disrupt rigid neural patterns, facilitating enhanced connectivity and fostering profound emotional breakthroughs that may alleviate symptoms of disorders like depression, anxiety, PTSD,...

Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression

American Journal of Psychiatry May 7, 2025 Matthew B. Wall, Lysia Demetriou, Bruna Giribaldi et al. 16 citations

Despite large improvements in depressive symptoms in the psilocybin group, psilocybin therapy had only a minor effect on brain responsiveness to emotional stimuli. These results are consistent with prior findings that the antidepressant action of SSRIs is often accompanied by a reduction in emotional responsiveness, but this effect may not occur in psychedelic therapy.

DOI: 10.1176/appi.ajp.20230751 (opens in new tab) Full text (opens in new tab) Psilocybin Cognitive neuroscience Depressive disorders Psychopharmacology +7

Psychedelic Therapies as Resistance to Neoliberalism: A Brazilian Schizoanalytical Perspective

Future Humanities May 1, 2025 Ernesto Grillo Rabello, Fabio Hebert da Silva

Psychedelic‐assisted therapies can be intertwined with the forces of neoliberal rationality, reductionist psychiatry, biomedical psychopharmacology, individualized models of subjectivity and fascism. Through a genealogical and critical review, this study seeks to demonstrate how the ongoing ‘psychedelic renaissance’ and its current medicalization of psychedelics may reinforce historical...

A Comprehensive Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Misuse

May 1, 2025 Eve E. Keighley, Dalia A Bedewy, Eid Abo Hamza et al. 1 citation preprint

Given the recent resurgence of using psychedelic drugs to treat substance misuse (SM), reviewing the latest information on their current status is essential. Substance use disorders (SUD) are psychiatric conditions that comprise the repetitive use of illicit substances, despite the harmful and damaging ramifications. Current treatment options for SUD are limited and have displayed low...

DOI: 10.31234/osf.io/mjhwf_v1 (opens in new tab) Meta-analysis Substance misuse Drug Psychoactive substance +1

Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series

Cephalalgia Reports May 1, 2025 Jonathan A. Leighton, Chieh Grace Lau, Aisha Savdo et al. 2 citations

Background Cluster headache is an excruciating condition for which standard treatments are usually insufficient. Evidence has accumulated that serotonergic psychedelic indoleamines including psilocybin and LSD can be effective in preventing attacks. Methods In this case series, nine patients with episodic and chronic cluster headache that didn’t respond to conventional treatments were treated...